Jeff DeMaso

603 posts

IVA Research

Vanguard’s Official Capital Gains Estimates: 2026

The official numbers are in. I’ve got all the data on the funds and ETFs that are paying, how much and when. And most importantly, I’ll tell you what to do about it.

| 19 min read
Weekly Brief

Beyond the Headlines

Vanguard confirms a breach | Capital gains estimates are out | Investor Choice expands | An emerging markets bond ETF arrives | Sprucegrove steps down | Pop quiz

| 8 min read
IVA Research

PRIMECAP Without the Giants

Same stock pickers, smaller stocks. I dig into PRIMECAP’s first ETF, going over how it compares with its six mutual fund siblings and why I’m buying it.

| 14 min read
Weekly Brief

Midterms, Markets and a Tech Hangover

Midterms and markets | Tech slides from its peak | Greenspan’s lesson

| 4 min read
IVA Research

Nibbling Around the Edges: 2026

Does the manager of your mutual fund (or ETF) have confidence in what he or she is doing? Are they invested alongside you?

| 11 min read
Monthly Recap

IVA MONTHLY RECAP | Quiet Victories

NOVEMBER 2026 | AI stumbles grabbed the headlines in October, while bonds, dividend growers and smaller stocks quietly delivered. Plus, IVA Portfolio notes, the IVA Factor Tracker and a roundup of articles and analysis from the past month.

| 8 min read